ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-1.02%(-0.0050) 1D
Nov 20, 4:10:08 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Beinsure
·
3 hours ago
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Traders Union
·
5 hours ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
The Loadstar
·
3 hours ago
CNBC: S&P 500 and Dow close in correction; Nasdaq erases 2026 gain as AI rout picks up steam
JournalArta
·
1 hour ago
S&P 500 Falls Into Correction as AI Worries Deepen
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd